Bausch Health Companies Inc. Share-based Payment Arrangement, Expense, Tax Benefit
Bausch Health Companies Inc. (BHC) reported Share-based Payment Arrangement, Expense, Tax Benefit of -$1.40 million for the 6-month period ending 2016-06-30, per its 10-Q filed 2016-08-09.
Discontinued › Expense Statement › Income Tax
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense · last filed 2018-08-10
- Bausch Health Companies Inc. share-based payment arrangement, expense, tax benefit for the quarter ending 2016-06-30 was $0.00, a 100.00% decline year-over-year.
- Bausch Health Companies Inc. share-based payment arrangement, expense, tax benefit for the quarter ending 2016-03-31 was -$1.40M, a 107.82% decline year-over-year.
- Bausch Health Companies Inc. share-based payment arrangement, expense, tax benefit for the quarter ending 2015-06-30 was $7.70M.
- Bausch Health Companies Inc. share-based payment arrangement, expense, tax benefit for the quarter ending 2015-03-31 was $17.90M.
- Bausch Health Companies Inc. share-based payment arrangement, expense, tax benefit for fiscal 2014 was $17.00M, a 29.75% decline from fiscal 2013.
- Bausch Health Companies Inc. share-based payment arrangement, expense, tax benefit for fiscal 2013 was $24.20M.
- Bausch Health Companies Inc. share-based payment arrangement, expense, tax benefit for fiscal 2011 was $26.50M.
| Period end | Share-based Payment Arrangement, Expense, Tax Benefit 3 month | Share-based Payment Arrangement, Expense, Tax Benefit 6 month | Share-based Payment Arrangement, Expense, Tax Benefit 12 month | Share-based Payment Arrangement, Expense, Tax Benefit 12 month as first filed |
|---|---|---|---|---|
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$1.40M 10-Q · filed 2016-08-09 | ||
| 2016-03-31 | -$1.40M 10-Q · filed 2016-06-07 | |||
| 2015-12-31 | $57.00M 8-K · filed 2018-08-10 | $56.80M 10-K · filed 2016-04-29 | ||
| 2015-06-30 | $7.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $25.60M 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | $17.90M 10-Q · filed 2016-06-07 | |||
| 2014-12-31 | $17.00M 10-K · filed 2017-03-01 | $17.10M 10-K · filed 2016-04-29 | ||
| 2013-12-31 | $24.20M 10-K · filed 2016-04-29 | |||
| 2011-12-31 | $26.50M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |